Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1999
11/18/1999WO1999051271A3 Compositions comprising glycol derivatives and alcohols
11/18/1999WO1999051216A3 3-pyridyloxyalkylamine or aryloxyalkylamine derivatives as cholinergic agonists
11/18/1999WO1999050269A3 Porphyrins and their use as photosensitizer
11/18/1999WO1999050255A3 Disubstituted pyrazolines and triazolines as factor xa inhibitors
11/18/1999WO1999049909A3 Revascularization apparatus having coaxial channeling and injecting means
11/18/1999WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
11/18/1999WO1999049854A3 Use of dexmedetomidine for icu sedation
11/18/1999WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999WO1999046284A9 Molecules that home to various selected organs or tissues
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999045949A3 Use of follistatin to modulate gdf-8 and bmp-11
11/18/1999WO1999045933A9 Novel delivery of hydroxy carboxylic acids
11/18/1999WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999CA2332616A1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and their uses
11/18/1999CA2331879A1 Oxyiminoalkanoic acid derivatives
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331735A1 Phenylurea and phenylthio urea derivatives
11/18/1999CA2331569A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2331118A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330557A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330555A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999CA2330212A1 Compositions and methods for active vaccination
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2328521A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999CA2328518A1 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
11/18/1999CA2328493A1 Transgenic plant-derived human blood coagulation factors
11/18/1999CA2328414A1 Methods for detecting and inhibiting angiogenesis
11/18/1999CA2328397A1 Human antithrombin iiis and methods related thereto
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2327386A1 Inhibition of protein kinases with piridinylimidazoles
11/18/1999CA2327354A1 Human apoptosis associated proteins
11/18/1999CA2327351A1 Cell signaling proteins
11/18/1999CA2327345A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
11/18/1999CA2326105A1 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0957091A1 Inhibitors of tumor necrosis factor alpha
11/17/1999EP0957087A2 Enzyme inhibitors
11/17/1999EP0957073A1 Novel derivatives of 3,3-diphenylpropylamines
11/17/1999EP0956860A1 Hematopoietic function restorative and processed food both containing treated peanut testae
11/17/1999EP0956854A1 Pharmaceutical composition comprising coenzyme q 10
11/17/1999EP0956351A1 A tumor necrosis factor related ligand
11/17/1999EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
11/17/1999EP0956299A1 Peptide antagonists of dp transcription factors
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
11/17/1999EP0956287A1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function
11/17/1999EP0956044A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
11/17/1999EP0956036A1 Anti-fibrotic agent assay
11/17/1999EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
11/17/1999EP0956032A1 Proteins and compositions for modulating mitosis
11/17/1999EP0956022A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
11/17/1999EP0956019A1 Novel therapeutic application of a thienycyclohexylamine derivative
11/17/1999EP0956002A1 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes
11/17/1999EP0819135B1 Sugar-modified cytostatics
11/17/1999EP0804576A4 A novel haemopoietin receptor
11/17/1999EP0784604B1 Process for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butan-1-ol
11/17/1999EP0741726B1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/17/1999EP0738273B1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
11/17/1999EP0572537B1 Cytokine inhibitors
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999CN1235554A Antifungal combination therapy
11/17/1999CN1235548A Method for lowering plasma levels of lipoprotein (A)
11/17/1999CN1235541A Treatment of spasticity, convulsions by isovaleric acid derivatives CNS
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235156A New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them
11/17/1999CN1235050A Prescription of Tongluofutanwan as medicine for activating collaterals and rehabilitating paralysis and preparing method thereof
11/17/1999CN1235049A Prescription of Yizhifutanwan for reinforcing wisdom and rehabilitating paralysis and preparing method thereof
11/17/1999CN1235029A Medicine for regulating menstruation and arresting bleeding and producing process therefor
11/17/1999CN1046525C Compounds containing fused bicyclic ring and preparation thereof
11/17/1999CN1046519C Oxazolyl- and thiazolylimidazo- and thienodiazepines and use as medicaments
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/17/1999CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/16/1999US5986132 Synthesis of carboxylic acid derivatives
11/16/1999US5986129 Multistage process of diazotization, acidification, hydrolysis and acylation
11/16/1999US5986108 Enzyme inhibitors
11/16/1999US5986103 2-alkyl-1H-imidazole-5-carboxylic acids
11/16/1999US5986100 Pharmaceutical compositions and methods for use
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986068 Luetinizing hormone, follicle stimulating hormone, thyroid stimulating hhormone and chronic gonadotropin linked with oligosaccharide
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986052 Fusion polypeptide containing fragments of cartilage matrix protein and link protein
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999US5985927 Medicaments for the selective treatment of tumor tissues
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985906 Use of a combination of the squalene epoxidase inhibitor terbinafine and an azole 14-alpha-methyldemethylase inhibitor (fluconazole or itraconazole) in mycotic infections caused by azole-resistant fungal strains
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985897 Benzothiphene compounds, intermediates, compositions, and methods
11/16/1999US5985895 2-naphthamide derivatives and their therapeutic applications
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985886 Endothelin receptor antagonists
11/16/1999US5985885 Useful in the treatment of hypertension, congestive heart failure, prostate hypertrophy, various urinary tract disorders and pathological symptoms caused by hyperactivity or disfunctioning of the noradrenergic neural system
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 1564